12:00 AM
 | 
Jul 30, 2007
 |  BioCentury  |  Regulation

Late-stage HRPC products

Late-stage HRPC products

Company Compound Description Ph III primary endpoint Status
GPC Biotech/ Spectrum Orplatna satraplatin Oral platinum compound

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >